Literature DB >> 30182325

A Novel Molecular Design for a Hybrid Phage-DNA Construct Against DKK1.

Saeed Khalili1,2, Mohamad Javad Rasaee3, Taravat Bamdad4, Maysam Mard-Soltani5, Majid Asadi Ghalehni6, Abolfazl Jahangiri7, Mohammad Hassan Pouriayevali8, Mohammad Reza Aghasadeghi8, Fatemeh Malaei2.   

Abstract

Nucleic acid immunization has recently exhibited a great promise for immunotherapy of various diseases. However, it is now clear that powerful strategies are imminently needed to improve their efficiency. In this regard, whole bacteriophage particles have been described as efficient DNA vaccine delivery vehicles, capable of circumventing the limitations of naked DNA immunization. Moreover, phage particles could be engineered to display specific peptides on their surfaces. Given these inherent characteristics of phages, we have designed a novel hybrid phage-DNA immunization vector using both M13 and pAAV plasmid elements. Following the construction and in vitro confirmation of the designed vectors, they were used for comparative mice immunization, carrying the same DNA sequence. The results indicated the efficacy of the designed hybrid phage particles, to elicit higher humoral immunity, in comparison to conventional DNA-immunization vectors (pCI). In light of these findings, it could be concluded that using adeno-associated virus (AAV) expression cassette along with displaying TAT peptide on the surface of the phage particle could be deemed as an appealing strategy to enhance the DNA-immunization and vaccination efficacy.

Entities:  

Keywords:  DKK1; DNA vaccination; Peptide display; Phage-DNA vaccination; TAT peptide

Mesh:

Substances:

Year:  2018        PMID: 30182325     DOI: 10.1007/s12033-018-0115-2

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  36 in total

1.  [3D structure of DKK1 indicates its involvement in both canonical and non-canonical Wnt pathways].

Authors:  S Khalili; M J Rasaee; T Bamdad
Journal:  Mol Biol (Mosk)       Date:  2017 Jan-Feb

2.  Highly conserved exposed immunogenic peptides of Omp34 against Acinetobacter baumannii: An innovative approach.

Authors:  Abolfazl Jahangiri; Iraj Rasooli; Parviz Owlia; Abbas Ali Imani Fooladi; Jafar Salimian
Journal:  J Microbiol Methods       Date:  2017-11-10       Impact factor: 2.363

3.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

Authors:  P Panina-Bordignon; A Tan; A Termijtelen; S Demotz; G Corradin; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

4.  Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors.

Authors:  Jean Philippe Richard; Kamran Melikov; Hilary Brooks; Paul Prevot; Bernard Lebleu; Leonid V Chernomordik
Journal:  J Biol Chem       Date:  2005-02-01       Impact factor: 5.157

5.  Protection of mice against Chlamydophila abortus infection with a bacteriophage-mediated DNA vaccine expressing the major outer membrane protein.

Authors:  Yong Ling; Wei Liu; Jason R Clark; John B March; Junjing Yang; Cheng He
Journal:  Vet Immunol Immunopathol       Date:  2011-08-09       Impact factor: 2.046

6.  Phage display particles expressing tumor-specific antigens induce preventive and therapeutic anti-tumor immunity in murine p815 model.

Authors:  Yuzhang Wu; Ying Wan; Jiang Bian; Jianping Zhao; ZhengCai Jia; Liyun Zhou; Wei Zhou; Yang Tan
Journal:  Int J Cancer       Date:  2002-04-10       Impact factor: 7.396

7.  Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells.

Authors:  A Eguchi; T Akuta; H Okuyama; T Senda; H Yokoi; H Inokuchi; S Fujita; T Hayakawa; K Takeda; M Hasegawa; M Nakanishi
Journal:  J Biol Chem       Date:  2001-05-09       Impact factor: 5.157

8.  Genetic immunisation against hepatitis B using whole bacteriophage lambda particles.

Authors:  John B March; Jason R Clark; Catherine D Jepson
Journal:  Vaccine       Date:  2004-04-16       Impact factor: 3.641

9.  Evaluation of an ompA-based phage-mediated DNA vaccine against Chlamydia abortus in piglets.

Authors:  Changbo Ou; Deyu Tian; Yong Ling; Qing Pan; Qing He; Francis O Eko; Cheng He
Journal:  Int Immunopharmacol       Date:  2013-05-11       Impact factor: 4.932

10.  An integrative in silico approach to the structure of Omp33-36 in Acinetobacter baumannii.

Authors:  Abolfazl Jahangiri; Iraj Rasooli; Parviz Owlia; Abbas Ali Imani Fooladi; Jafar Salimian
Journal:  Comput Biol Chem       Date:  2018-01-12       Impact factor: 2.877

View more
  4 in total

1.  A unique antigen against SARS-CoV-2, Acinetobacter baumannii, and Pseudomonas aeruginosa.

Authors:  Mohammad Reza Rahbar; Shaden M H Mubarak; Anahita Hessami; Bahman Khalesi; Navid Pourzardosht; Saeed Khalili; Kobra Ahmadi Zanoos; Abolfazl Jahangiri
Journal:  Sci Rep       Date:  2022-06-27       Impact factor: 4.996

Review 2.  Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous viruses.

Authors:  Julia Fakhiri; Dirk Grimm
Journal:  Mol Ther       Date:  2021-04-05       Impact factor: 11.454

Review 3.  Drug Discovery of DKK1 Inhibitors.

Authors:  Hewen Jiang; Zongkang Zhang; Yuanyuan Yu; Hang Yin Chu; Sifan Yu; Shanshan Yao; Ge Zhang; Bao-Ting Zhang
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

4.  Atezolizumab and granzyme B as immunotoxin against PD-L1 antigen; an insilico study.

Authors:  Fateme Sefid; Zahra Payandeh; Ghasem Azamirad; Behzad Baradaran; Mohsen Nabi Afjadi; Maryam Islami; Maryam Darvish; Seyed Mehdi Kalantar; Houman Kahroba; Mahnam Alaei Ardakani
Journal:  In Silico Pharmacol       Date:  2021-02-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.